Grant: Operating Grant: Industry-partnered Collaborative Research - Other Partner
University of Alberta
$131,484.00
Omega-3 Fatty Acids for Treatment of Intestinal Failure Associated Liver Disease: A Translational Research Study
FY 2010-11
Summary
Liver disease is the main cause of death in babies and children who depend on intravenous nutrition because their bowel is not adequate to absorb nutrients from food. The most common cause of this so called intestinal failure is short bowel syndrome, when babies are born without part of the bowel or lose bowel length with surgeries needed after birth. Early studies we conducted in piglets in our institution suggested that using a fish based intravenous fat rather then a soy based intravenous fat might improve this liver disease. Soy is the most common intravenous fat used in Canada. Many childrens hospitals around Canada have since started using the fish oil for intestinal failure and other conditions even though we don't fully understand how it works or what the risks might be for babies who depend on fat to grow. We can help provide some answers by going back to our original baby piglet model. It is not possible to undertake some kinds of research studies in sick human babies to answer these questions. We cannot always do studies in sick babies quickly to gain answers, but we can do this with animal studies. Our research group includes frontline clinicians, who care for these babies, as well as senior nutrition scientists, who are motivated to undertake this research to advance and improve how we are currently looking after sick babies with intestinal failure.
Department
Program
Operating Grant: Industry-partnered Collaborative Research - Other Partner
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
221585
Name
Turner Justine M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Industry Partnered Collaborative Research
Projecttitle
Omega-3 Fatty Acids for Treatment of Intestinal Failure Associated Liver Disease: A Translational Research Study
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$131,484
Cihrequipment2
$0
Programname2
Operating Grant: Industry-partnered Collaborative Research - Other Partner
Keyworddelim
Intestinal Failure; Intestinal Failure Associated Liver Disease; Liver Disease; Parenteral Nutrition; Polyunsaturated Fatty Acids
Abstract
Liver disease is the main cause of death in babies and children who depend on intravenous nutrition because their bowel is not adequate to absorb nutrients from food. The most common cause of this so called intestinal failure is short bowel syndrome, when babies are born without part of the bowel or lose bowel length with surgeries needed after birth. Early studies we conducted in piglets in our institution suggested that using a fish based intravenous fat rather then a soy based intravenous fat might improve this liver disease. Soy is the most common intravenous fat used in Canada. Many childrens hospitals around Canada have since started using the fish oil for intestinal failure and other conditions even though we don't fully understand how it works or what the risks might be for babies who depend on fat to grow. We can help provide some answers by going back to our original baby piglet model. It is not possible to undertake some kinds of research studies in sick human babies to answer these questions. We cannot always do studies in sick babies quickly to gain answers, but we can do this with animal studies. Our research group includes frontline clinicians, who care for these babies, as well as senior nutrition scientists, who are motivated to undertake this research to advance and improve how we are currently looking after sick babies with intestinal failure.
Competitiondate
201009
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Turner, Justine M
Approvedterm
3 ans 0 mois
Cihrcontribution2
Knowledge Translation Branch~ $131,484~ $0~